These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7654890)

  • 1. Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies.
    Kimmig JM
    Aliment Pharmacol Ther; 1995 Jun; 9(3):281-6. PubMed ID: 7654890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.
    Tytgat GN; Anker Hansen OJ; Carling L; de Groot GH; Geldof H; Glise H; Efskind P; Elsborg L; Karvonen AL; Ohlin B
    Scand J Gastroenterol; 1992; 27(3):175-83. PubMed ID: 1502478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial.
    McDougall NI; Watson RG; Collins JS; McFarland RJ; Love AH
    Aliment Pharmacol Ther; 1997 Jun; 11(3):487-95. PubMed ID: 9218071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healing and prevention of relapse of reflux oesophagitis by cisapride.
    Toussaint J; Gossuin A; Deruyttere M; Hublé F; Devis G
    Gut; 1991 Nov; 32(11):1280-5. PubMed ID: 1752455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.
    Sontag SJ; Robinson M; Roufail W; Hirschowitz BI; Sabesin SM; Wu WC; Behar J; Peterson WL; Kranz KR; Tarnawski A; Dayal Y; Berman R; Simon TJ
    Aliment Pharmacol Ther; 1997 Apr; 11(2):373-80. PubMed ID: 9146778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine.
    Geldof H; Hazelhoff B; Otten MH
    Aliment Pharmacol Ther; 1993 Aug; 7(4):409-15. PubMed ID: 8218755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.
    Bate CM; Booth SN; Crowe JP; Mountford RA; Keeling PW; Hepworth-Jones B; Taylor MD; Richardson PD
    Gut; 1995 Apr; 36(4):492-8. PubMed ID: 7737552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.
    Blum AL; Adami B; Bouzo MH; Brandstätter G; Fumagalli I; Galmiche JP; Hebbeln H; Hentschel E; Hüttemann W; SChütz E
    Dig Dis Sci; 1993 Mar; 38(3):551-60. PubMed ID: 8444088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
    Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T
    Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian clinical trials of omeprazole in the management of reflux oesophagitis.
    Dent J
    Digestion; 1990; 47 Suppl 1():69-71. PubMed ID: 2093019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis.
    Hatlebakk JG; Berstad A
    Aliment Pharmacol Ther; 1997 Apr; 11(2):365-72. PubMed ID: 9146777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.
    Laursen LS; Havelund T; Bondesen S; Hansen J; Sanchez G; Sebelin E; Fenger C; Lauritsen K
    Scand J Gastroenterol; 1995 Sep; 30(9):839-46. PubMed ID: 8578181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing and relapse of severe peptic esophagitis after treatment with omeprazole.
    Hetzel DJ; Dent J; Reed WD; Narielvala FM; Mackinnon M; McCarthy JH; Mitchell B; Beveridge BR; Laurence BH; Gibson GG
    Gastroenterology; 1988 Oct; 95(4):903-12. PubMed ID: 3044912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo.
    Bardhan KD; Cherian P; Vaishnavi A; Jones RB; Thompson M; Morris P; Brooks A; D'Silva J; Gillon KR; Wason C; Patterson J; Polak J; Bishop A
    Gut; 1998 Oct; 43(4):458-64. PubMed ID: 9824569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two dosing regimens of cisapride in the treatment of reflux oesophagitis.
    Schütze K; Bigard MA; Van Waes L; Hinojosa J; Bedogni G; Hentschel E
    Aliment Pharmacol Ther; 1997 Jun; 11(3):497-503. PubMed ID: 9218072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.